Pv. Algvere et al., TRANSPLANTATION OF RPE IN AGE-RELATED MACULAR DEGENERATION - OBSERVATIONS IN DISCIFORM LESIONS AND DRY RPE ATROPHY, Graefe's archive for clinical and experimental ophthalmology, 235(3), 1997, pp. 149-158
A study was carried out to investigate whether human RPE allografts ar
e tolerated or rejected in the subretinal space and to determine the f
easibility of RPE transplantation in subjects with age-related macular
degeneration (AMD). Methods: Patches of human fetal RPE (13-20 weeks
of gestational age) were transplanted into the subretinal space of fiv
e patients after surgical removal of subfoveal fibrovascular membranes
, and to four subjects with dry geographic atrophy. Suspensions of RPE
cells were transplanted to four other patients with nonexudative AMD.
Results were evaluated with clinical ophthalmological examination, SL
O microperimetry and fluorescein angiography over 8-20 months. Results
: In disciform lesions, RPE transplants developed macular edema and fl
uorescein leakage concomitant with gradual reduction of visual acuity,
implying host-graft rejection, over 1-6 months. In geographic atrophy
, three of four transplants showed little change in shape and size aft
er 12 months (one transplant was slowly rejected). In non-exudative AM
D, RPE suspension transplants showed no evidence of rejection and were
associated with the disappearance of drusen; visual acuity remained s
table and SLO microperimetry confirmed retinal function over the trans
planted area. Conclusion: Human RPE allografts are not invariably reje
cted in the subretinal space without immunosuppression. The rejection
rate is lower in nonexudative than in neovascular AMD. An intact blood
-retinal barrier is likely to protect against rejection. It is technic
ally feasible to transplant human RPE into the submacular space withou
t adversely affecting visual function in nonexudative AMD over relativ
ely long periods of time.